US Patent Issued to Novo Nordisk on Feb. 24 for "Injection device for delivering a predefined plurality of predetermined dose volumes" (Danish Inventor)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,493, issued on Feb. 24, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).

"Injection device for delivering a predefined plurality of predetermined dose volumes" was invented by Bjoern Gullak Larsen (Birkeroed, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a spring driven multi-use fixed dose injection device with an End-of-Content (EoC) mechanism. A housing structure contains a volume of a liquid drug which is expelled in a predefined number of substantially equally sized dose volumes. Each dose volume is expelled automatically with the assistance of a spring which is loaded with a force sufficient to expel the...